Through the analysis of scRNA-seq data, pharmaceutical companies can address a variety of questions, such as patient stratification, understanding cell-cell interactions, assessing heterogeneity, and investigating mechanisms of action and drug combinations.
In this webinar, we will discuss the potential of scRNA-seq analysis in the context of pharmaceutical research. We will also touch on emerging techniques such as CITE-seq, Spatial transcriptomics, scRNA-seq + ATAC-seq, and TCR repertoire, and discuss how they can be used to further advance pharmaceutical research.
How can scRNA-seq analysis be used to assess cell heterogeneity in preclinical and clinical studies?
What insights can be gained from scRNA-seq analysis to understand the mechanism of action of drugs or drug combinations?
How does scRNA-seq analysis help in understanding cell-cell interaction in the context of pharmaceutical research?
What are some of the novel techniques that are emerging in the field of scRNA-seq analysis?